<DOC>
	<DOCNO>NCT01414387</DOCNO>
	<brief_summary>Carotid artery stenting ( CAS ) cerebral embolic protection prefer treatment narrow carotid artery patient high risk open surgery . Special device use protect brain particle ( embolus ) may break narrowing blockage clear angioplasty stenting procedure . Although filter frequently use , protection system consist balloon flow reversal also available cerebral embolic protection . However , little information effectiveness filter compare balloon flow reversal prevention embolization CAS . The aim study address major problem . Our study design answer two specific question : First , study investigate whether balloon-based protection system effective filter reduce amount particle break travel brain CAS . For purpose two image technique use : magnetic resonance imaging brain ( MRI ) , transcranial doppler ( detection microparticles small brain vessel use ultrasound ) . Second , investigate whether use balloon-based protection device effective filter prevention stroke , heart attack , death carotid stenting . The result study provide important information find best way protect brain plaque fragment may break CAS .</brief_summary>
	<brief_title>Effects Cerebral Protection With Filters vs. Flow Reversal Cerebral Embolization After Carotid Artery Stenting</brief_title>
	<detailed_description>Description Procedures perform Pre-Procedure Medication Regimen The standard care premedication antiplatelet therapy CAS use study . To minimize risk neurological event related stent thrombosis procedure , subject provide antiplatelet therapy minimum 48 72 hour prior procedure , include : 1 ) Aspirin 325 mg daily 2 ) Clopidogrel ( Plavix® ) 75 mg twice daily OR Ticlopidine ( Ticlid® ) 250 mg twice daily A protract dose premedication may substitute administer load dose antiplatelet therapy least 4 hour prior carotid intervention day procedure , include : 1 ) Aspirin A 650 mg load dose aspirin , provide enteric coat extended release , 2 ) Clopidogrel ( Plavix ® ) 450 mg. Procedure : Patients undergo CAS FDA-approved carotid stent embolic protection Accunet device Gore NPS . All CAS procedure perform retrograde access common femoral artery . CAS procedure perform use fix angiographic unit ( Allura Xper FD20 , Philips , Bothell , WA ) . Procedural detail CAS protocol follow technique describe detail before.14 The procedure perform local anesthesia minimal sedation facilitate continuous neurological evaluation . Baseline angiographic study perform concurrently CAS procedure . The diagnostic angiography review ensure patient meet applicable angiographic exclusion criterion . Once determine , randomization perform . The Accunet filter Gore NPS use accord instruction use . Ultrasound-guided access ipsilateral contralateral femoral vein obtain patient randomize CAS Gore NPS . Neurological monitoring subject 's level awareness evaluate every 5 10 minute CAS procedure . Patients deem ineligible angiographic criterion consider screen failure exclude study . These patient may receive treatment outside study protocol accord usual practice standard care . Transcranial Doppler Protocol : Transcranial Doppler signal , use portable digital 2-MHz PMD/spectral TCD unit ( PMD150 , Spencer Technologies , Seattle , WA ) , record bilateral middle cerebral artery via transtemporal window . Monitoring start operative room immediately CAS continue end case least 15 minute removal neuroprotection system . A head frame use ultrasound probe fixation continuous flow assessment M1 segment middle cerebral artery ( MCA ) . Several TCD parameter record : MES count microemboli shower detection different step procedure , initial MCA mean velocity , mean MCA velocity CAS , final mean MCA velocity . MES identify accord recommend guidelines.31 Data store hard disk use cod system analyze off-line later day reader blind patient information . Diffusion-weighted MRI exam : All patient DW-MRI scan brain obtain within 24 hour prior CAS 18 24 hour CAS . Postprocedural DW-MRI study compare preprocedural study identify new procedure-related ischemic cerebral lesions.32 , 33 DW-MRI obtain use standard head coil 1.5 Tesla Siemens scanner ( Siemens Avanto Magnetom Sonata , Siemens , Erlangen , Germany ) . DW-MRI echo-planar imaging sequence ( B0 = 1000 ) fluid-attenuated inversion recovery ( FLAIR ) image obtain axial coronal section . The DW-MRI study evaluate neuroradiologists blind clinical status , type embolic protection TCD data patient . On postprocedural MRI , acute embolic lesion define focal hyperintense area restrict diffusion signal , confirm apparent diffusion coefficient mapping rule artifact . New postprocedural cerebral lesion consistent microemboli record term location number DW-MRI exam perform .</detailed_description>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>1 . Patient least 18 year old ; 2 . Patient willing capable comply study protocol requirement , include specify followup period ; 3 . Patient willing provide write informed consent prior enrollment study ; 4 . Male , infertile female , nonlactating female child bear potential practicing acceptable method birth control negative pregnancy test within 7days prior study procedure ; 5 . Patient either symptomatic , i.e . history TIAs nondisabling stroke within 6 month procedure , carotid stenosis ≥ 50 % , asymptomatic carotid stenosis ≥ 80 % , diagnose angiography use NASCET methodology ; 4 6 . The target lesion locate internal carotid artery ( ICA ) reference vessel diameter , i.e . common carotid artery ( CCA ) &lt; 10 mm base angiographic assessment . 1 . Acute evolve recent stroke within 7 day study evaluation ; 2 . Cardiac embolism ; 3 . Acute myocardial infarction le 72 hour prior procedure ; 4 . Major surgical procedure within 30 day precede CAS ; 5 . Major surgical procedure within 30 day index procedure ; 6 . Prior major ipsilateral stroke residual deficit neurologic condition may affect neurological assessment ; 7 . Pregnancy breastfeeding ; 8 . Severe chronic renal insufficiency ( serum creatinine ≥ 2.5 mg/dL ) ; 9 . Contraindication study medication , include antiplatelet therapy ; 10 . Prior sensitivity contrast medium adequately control premedication ; 11 . Untreatable bleed diathesis hypercoagulable state refusal blood transfusion ; 12 . History uncontrolled pulmonary hypertension ; 13 . Intracranial pathology ; 14 . Patient unable unwilling undergo DWMRI brain 15 . Patient without adequate transtemporal window transcranial Doppler examination 16 . Other anatomic comorbid condition , investigator 's opinion , could limit patient 's ability participate study comply followup requirement , impact scientific soundness study result . 17 . Isolated ipsilateral hemisphere lead subject intolerance flow reversal ; 18 . Anatomic condition preclude performance carotid artery stenting .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>carotid stenosis</keyword>
	<keyword>cerebral embolization</keyword>
	<keyword>stent</keyword>
	<keyword>stroke</keyword>
</DOC>